VivoSim Labs, Inc. (VIVS)
VivoSim Labs Market Cap : 0.4986M for Oct. 29, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 28, 2026 | 0.4654M |
| October 27, 2026 | 0.4801M |
| October 26, 2026 | 0.4855M |
| October 23, 2026 | 0.4744M |
| October 22, 2026 | 0.5092M |
| October 21, 2026 | 0.5654M |
| October 20, 2026 | 0.5472M |
| October 19, 2026 | 0.5031M |
| October 16, 2026 | 0.5012M |
| October 15, 2026 | 0.5462M |
| October 14, 2026 | 0.514M |
| October 13, 2026 | 0.5564M |
| October 12, 2026 | 0.5558M |
| October 09, 2026 | 0.5753M |
| October 08, 2026 | 0.566M |
| October 07, 2026 | 0.6117M |
| October 06, 2026 | 0.6449M |
| October 05, 2026 | 0.6593M |
| October 02, 2026 | 0.6274M |
| October 01, 2026 | 0.6628M |
| September 30, 2026 | 0.6772M |
| September 29, 2026 | 0.6468M |
| September 28, 2026 | 0.7034M |
| September 25, 2026 | 0.7155M |
| September 24, 2026 | 0.72M |
| Date | Value |
|---|---|
| September 23, 2026 | 0.7318M |
| September 22, 2026 | 0.7516M |
| September 21, 2026 | 0.7931M |
| September 18, 2026 | 0.7251M |
| September 17, 2026 | 0.8276M |
| September 16, 2026 | 0.8372M |
| September 15, 2026 | 0.8704M |
| September 14, 2026 | 0.8979M |
| September 11, 2026 | 0.9043M |
| September 10, 2026 | 0.9577M |
| September 09, 2026 | 0.8784M |
| September 08, 2026 | 0.8998M |
| September 04, 2026 | 0.8887M |
| September 03, 2026 | 0.8912M |
| September 02, 2026 | 0.8938M |
| September 01, 2026 | 0.8903M |
| August 31, 2026 | 0.9308M |
| August 28, 2026 | 0.9113M |
| August 27, 2026 | 0.9359M |
| August 26, 2026 | 0.9295M |
| August 25, 2026 | 0.9315M |
| August 24, 2026 | 0.9327M |
| August 21, 2026 | 0.9136M |
| August 20, 2026 | 0.8864M |
| August 19, 2026 | 0.8858M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
Market Cap Benchmarks
| Agenus, Inc. | 301.93M |
| Amgen, Inc. | 249.08B |
| Anika Therapeutics, Inc. | 291.35M |
| BioCryst Pharmaceuticals, Inc. | 2.177B |
| Imunon, Inc. | 3.868M |
Market Cap Related Metrics
| PS Ratio | 4.552 |
| Price | 0.1561 |
| Earnings Yield | -2.86K% |